Annexon prices $125M public offering of common stock and pre-funded warrants

Annexon, Inc.

Priced 13,001,120 shares at $6.25/sh and 7M pre-funded warrants at $6.249/sh; gross proceeds $125M.
Net proceeds expected ~$116.9M after underwriting discounts and expenses; offering closed June 7, 2024.
Underwriters granted 30-day option to purchase up to 3,000,168 additional shares.
J.P. Morgan, Jefferies, TD Cowen, BofA Securities and Wells Fargo Securities served as joint book-running managers.
Funds will support development of classical complement-mediated neuroinflammatory therapies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.